Trial of Topical Cidofovir for the Prevention of Hair Growth
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is a two-arm, single center placebo-controlled double-blind proof of concept study which
will evaluate the safety and efficacy of topical cidofovir (both 1% and 3%)compared to
placebo for the prevention of hair growth.